Canada’s generic drug king found himself on the wrong side of several shaking fingers in the past year. After Health Canada demanded a recall of Apotex’s mispackaged birth control pills (they contained too many placebos and not enough medication), the U.S. Food and Drug Administration threatened to block Apotex products for “repeated deficiencies,” including bacterial contamination. Meanwhile, a Florida judge ruled against the pharmaceutical company in a lawsuit where Apotex claimed Brussels-based UCB infringed on its patent for a manufacturing process for a blood pressure medication. United States District Judge Donald M. Middlebrooks had some harsh words for Sherman, who took the stand himself. “Dr. Sherman engaged in affirmative and egregious misconduct” throughout the patent prosecution, Judge Middlebrooks wrote.
St. Joseph Communications uses cookies for personalization, to customize its online advertisements, and for other purposes. Learn more or change your cookie preferences. By continuing to use our service, you agree to our use of cookies.
We use cookies (why?) You can change cookie preferences. Continued site use signifies consent.